Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) has shared an announcement.
Recordati has disclosed the sale of treasury shares to beneficiaries of its stock option plans, following the exercise of options previously granted under these incentive schemes. The sale price for the shares matches the original exercise price set at grant, indicating that the transactions are purely linked to remuneration mechanisms rather than market-driven disposals.
During April 2026 the company sold a total of 35,000 shares on the Italian market across five transactions, at weighted average prices of €47.52 and €45.97. These movements slightly reduce Recordati’s treasury share holdings while fulfilling commitments under employee and management incentive plans, aligning equity compensation with shareholder-approved structures.
The most recent analyst rating on (IT:REC) stock is a Buy with a EUR57.50 price target. To see the full list of analyst forecasts on Recordati Industria Chimica e Farmaceutica SPA stock, see the IT:REC Stock Forecast page.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati Industria Chimica e Farmaceutica S.p.A. is an Italian pharmaceutical company headquartered in Milan, operating in the healthcare sector with a focus on prescription medicines and specialty pharma products. The company is listed on the Italian market and its shares trade under ISIN code IT0003828271, reflecting its role as a significant player in Italy’s pharmaceutical industry.
Average Trading Volume: 385,205
Technical Sentiment Signal: Strong Buy
Current Market Cap: €10.29B
See more data about REC stock on TipRanks’ Stock Analysis page.